S1 Ep10: COBRRA Trial Results Raise Questions About VTE Management

episode

Previously titled “10: COBRRA Trial Results Raise Questions About VTE Management” — renamed by the publisher on Aug 31, 2026

The Tell-Tale Heart: The Pharmacist's Cardiovascular Digest not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

recent transcribed audio

Can Toia Shut Herbie Down? Penrith's Vulnerable State & Moses' Lebanon Exit!| NRL Daily 47 min · 24 Sep 2026 · Triple M Rocks Footy NRL

Ask, Tell, Confess: I Can't Believe He CHEATED?! 31 min · 24 Sep 2026 · Dumb Blonde

NPR News: 09-23-2026 10PM EDT 4 min · 24 Sep 2026 · NPR News Now

10PM ET 09/23/2026 Newscast 3 min · 24 Sep 2026 · Fox News Hourly Update

Xi in Washington, US-China Trade Truce Extended, More 8 min · 24 Sep 2026 · Bloomberg News Now

Whateley in a Snapshot | Thursday (24.09.26) 6 min · 24 Sep 2026 · Whateley

Report any issue

Source

Recorded15 Jul 2025

Publisheraudioboom.com ↗

Handlerec:11169931

Show notes

This week, host Craig Beavers sat down with Tara Lech, PharmD, CACP, director of anticoagulation services at Beth Israel Lahey Health, to discuss recent findings from the COBBRA trial, which compared bleeding risk with rivaroxaban versus apixaban.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related